BioCentury | Dec 31, 2020
Regulation

119 drugs added to China’s reimbursement list, which includes more domestic PD-1s

...edaravone/dexborneol from Simcere Pharmaceutical Group Ltd. (HKEX:2096) for stroke, Fu Lamei polyethylene glycol loxenatide from Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Apr 24, 2020
Product Development

April 23 Quick Takes: Hansoh, NiKang partner for antiviral; plus Jakafi, Avastin, EpimAb-QIMR, ProThera-Takeda

...Hansoh gains China rights to NiKang antiviral Hansoh Pharmaceutical Group Co. Ltd. (HKEX:03692) gained rights to develop and commercialize NKT-1992...
...#), ruxolitinib (Generic), Jakavi (Other), Jakafi (Other) EpimAb Biotherapeutics Inc. QIMR Berghofer Medical Research Institute Takeda Pharmaceutical Co. Ltd. Hansoh Pharmaceutical Group Co. Ltd. Novartis...
BioCentury | Dec 21, 2019
Politics, Policy & Law

U.S. drug industry hopes China deal ends stealth attack on IP

...of the anticoagulant Eliquis apixaban in China. Patents on Eliquis run until September 2022, but Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Sep 19, 2019
Tools & Techniques

Atomwise's JV spree

...Atomwise Inc. announced three JVs with U.S.-based cancer companies and a collaboration with Chinese pharma Hansoh Pharmaceutical Group Co. Ltd....
...HEXIM1 - Hexamethylene bis-acetamide inducible 1 KDM5B - Lysine-specific demethylase 5B Karen Tkach Tuzman, Associate Editor Atomwise Inc. Hansoh Pharmaceutical Group Co. Ltd. AI computational...
BioCentury | Sep 18, 2019
Financial News

Hong Kong’s first IPO in months values Shanghai Henlius at $3.4B

...HK$1.2 billion in an IPO that valued the biosimilars company at HK$6.2 billion. In June, Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Sep 13, 2019
Company News

Sept. 12 Company Quick Takes: Atomwise in China deal; plus Ardelyx, GSK, Amarin, deCode

...drug discovery deal AI-based drug discovery company Atomwise Inc. (San Francisco, Calif.) has partnered with Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...on average $87.9 million per financing. Excluding the largest outlier from the gainer cohort -- Hansoh Pharmaceutical Group Co. Ltd.’s...
...NASDAQ:PRVL) 6/19/19 $125.0 $578.0 $448.8 -22% Stoke Therapeutics Inc. (NASDAQ:STOK) 6/18/19 $163.3 $587.6 $952.2 62% Hansoh Pharmaceutical Group Co. Ltd....
...NYSE:LLY), Indianapolis, Ind. Fulcrum Therapeutics Inc., Cambridge, Mass. Gossamer Bio Inc. (NASDAQ:GOSS), San Diego, Calif. Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Jun 29, 2019
Finance

Biotech backs down in 2Q19

...losing a median of 1%, and $2.5 billion in market cap. Leading the group was Hansoh Pharmaceutical Group Co. Ltd....
...Mass. American Society of Clinical Oncology (ASCO), Alexandria, Va. Exact Sciences Corp. (NASDAQ:EXAS), Madison, Wisc. Hansoh Pharmaceutical Group Co. Ltd....
...kinase Meredith Durkin Wolfe, Associate Editor, Data & Analytics Adaptive Biotechnologies Corp. Alkermes plc ArQule Inc. Array BioPharma Inc. Exact Sciences Corp. Hansoh Pharmaceutical Group Co. Ltd. InflaRx...
BioCentury | Jun 14, 2019
Financial News

June 14 Financial Quick Takes: Hargreaves pulls out of Woodford fund; plus Hansoh, Seres, Transgene

...see "Woodford Suspends Trade in Flagship Fund ”). Hansoh shares jump in Hong Kong debut Hansoh Pharmaceutical Group Co. Ltd....
...€2.34 in a rights issue, which is expected to close June 27. Elizabeth S. Eaton, Staff Writer Hansoh Pharmaceutical Group Co. Ltd. Seres...
BioCentury | Jun 13, 2019
Financial News

June 13 Financial Quick Takes: Hansoh prices $1B HKEX IPO; plus Provention, Genome Medical, InGeneron and more

...Hansoh gets $10B-plus valuation via Hong Kong IPO Hansoh Pharmaceutical Group Co. Ltd. (HKSE:03692) priced its Hong Kong IPO Thursday...
...to sell ordinary shares in a concurrent European private placement. Elizabeth S. Eaton, Staff Writer ADC Therapeutics S.A. Hansoh Pharmaceutical Group Co. Ltd. InGeneron...
Items per page:
1 - 10 of 15
BioCentury | Dec 31, 2020
Regulation

119 drugs added to China’s reimbursement list, which includes more domestic PD-1s

...edaravone/dexborneol from Simcere Pharmaceutical Group Ltd. (HKEX:2096) for stroke, Fu Lamei polyethylene glycol loxenatide from Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Apr 24, 2020
Product Development

April 23 Quick Takes: Hansoh, NiKang partner for antiviral; plus Jakafi, Avastin, EpimAb-QIMR, ProThera-Takeda

...Hansoh gains China rights to NiKang antiviral Hansoh Pharmaceutical Group Co. Ltd. (HKEX:03692) gained rights to develop and commercialize NKT-1992...
...#), ruxolitinib (Generic), Jakavi (Other), Jakafi (Other) EpimAb Biotherapeutics Inc. QIMR Berghofer Medical Research Institute Takeda Pharmaceutical Co. Ltd. Hansoh Pharmaceutical Group Co. Ltd. Novartis...
BioCentury | Dec 21, 2019
Politics, Policy & Law

U.S. drug industry hopes China deal ends stealth attack on IP

...of the anticoagulant Eliquis apixaban in China. Patents on Eliquis run until September 2022, but Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Sep 19, 2019
Tools & Techniques

Atomwise's JV spree

...Atomwise Inc. announced three JVs with U.S.-based cancer companies and a collaboration with Chinese pharma Hansoh Pharmaceutical Group Co. Ltd....
...HEXIM1 - Hexamethylene bis-acetamide inducible 1 KDM5B - Lysine-specific demethylase 5B Karen Tkach Tuzman, Associate Editor Atomwise Inc. Hansoh Pharmaceutical Group Co. Ltd. AI computational...
BioCentury | Sep 18, 2019
Financial News

Hong Kong’s first IPO in months values Shanghai Henlius at $3.4B

...HK$1.2 billion in an IPO that valued the biosimilars company at HK$6.2 billion. In June, Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Sep 13, 2019
Company News

Sept. 12 Company Quick Takes: Atomwise in China deal; plus Ardelyx, GSK, Amarin, deCode

...drug discovery deal AI-based drug discovery company Atomwise Inc. (San Francisco, Calif.) has partnered with Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Jul 13, 2019
Finance

How crossover, insider support and big money correlated with performance across 1H19 IPOs

...on average $87.9 million per financing. Excluding the largest outlier from the gainer cohort -- Hansoh Pharmaceutical Group Co. Ltd.’s...
...NASDAQ:PRVL) 6/19/19 $125.0 $578.0 $448.8 -22% Stoke Therapeutics Inc. (NASDAQ:STOK) 6/18/19 $163.3 $587.6 $952.2 62% Hansoh Pharmaceutical Group Co. Ltd....
...NYSE:LLY), Indianapolis, Ind. Fulcrum Therapeutics Inc., Cambridge, Mass. Gossamer Bio Inc. (NASDAQ:GOSS), San Diego, Calif. Hansoh Pharmaceutical Group Co. Ltd....
BioCentury | Jun 29, 2019
Finance

Biotech backs down in 2Q19

...losing a median of 1%, and $2.5 billion in market cap. Leading the group was Hansoh Pharmaceutical Group Co. Ltd....
...Mass. American Society of Clinical Oncology (ASCO), Alexandria, Va. Exact Sciences Corp. (NASDAQ:EXAS), Madison, Wisc. Hansoh Pharmaceutical Group Co. Ltd....
...kinase Meredith Durkin Wolfe, Associate Editor, Data & Analytics Adaptive Biotechnologies Corp. Alkermes plc ArQule Inc. Array BioPharma Inc. Exact Sciences Corp. Hansoh Pharmaceutical Group Co. Ltd. InflaRx...
BioCentury | Jun 14, 2019
Financial News

June 14 Financial Quick Takes: Hargreaves pulls out of Woodford fund; plus Hansoh, Seres, Transgene

...see "Woodford Suspends Trade in Flagship Fund ”). Hansoh shares jump in Hong Kong debut Hansoh Pharmaceutical Group Co. Ltd....
...€2.34 in a rights issue, which is expected to close June 27. Elizabeth S. Eaton, Staff Writer Hansoh Pharmaceutical Group Co. Ltd. Seres...
BioCentury | Jun 13, 2019
Financial News

June 13 Financial Quick Takes: Hansoh prices $1B HKEX IPO; plus Provention, Genome Medical, InGeneron and more

...Hansoh gets $10B-plus valuation via Hong Kong IPO Hansoh Pharmaceutical Group Co. Ltd. (HKSE:03692) priced its Hong Kong IPO Thursday...
...to sell ordinary shares in a concurrent European private placement. Elizabeth S. Eaton, Staff Writer ADC Therapeutics S.A. Hansoh Pharmaceutical Group Co. Ltd. InGeneron...
Items per page:
1 - 10 of 15